Preliminary definition of improvement in juvenile arthritis

Arthritis and Rheumatism

Volumn 40, Issue 7, 1997, Pages 1202-1209

  Giannini, Edward H ^a   Ruperto, Nicolino ^b   Ravelli, Angelo ^b   Lovell, Daniel J ^a   Felson, David T ^c   Martini, Alberto ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF PAVIA   (Italy)

^c BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; PLACEBO;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; FUNCTIONAL ASSESSMENT; HUMAN; JOINT MOBILITY; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME; WELLBEING;

EID: 0030960980     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R     Document Type: Article

References (16)

1. Giannini EH, Brewer EJ: Poor correlation between the erythrocyte sedimentation rate and clinical activity in juvenile rheumatoid arthritis. Clin Rheumatol 6:197-201, 1987
2. Ruperto N, Giannini EH: Redundancy of conventional articular response variables used in juvenile chronic arthritis clinical trials. Ann Rheum Dis 55:73-75, 1996
3. Giannini EH, Stillman CM, Brewer EJ: Measuring grip strength in children with the Martin Vigorimeter and adapted sphygmomanometer cuff. Occup Ther J Res 4:234-236, 1984
4. Anderson JJ, Felson DT, Meenan RF, Williams HJ: Which traditional measures should be used in rheumatoid arthritis clinical trials? Arthritis Rheum 32:1093-1099, 1989
5. Felson DT, Anderson JJ, Meenan RF: Time for changes in the design analysis, and reporting of rheumatoid arthritis clinical trials. Arthritis Rheum 33:140-149, 1990
6. Felson DT: Choosing a core set of disease activity measures for rheumatoid arthritis clinical trials. J Rheumatol 20:531-534, 1993
7. Giannini EH, Lovell DJ, Hepburn B: FDA draft guidelines for the clinical evaluation of antiinflammatory and antirheumatic drugs in children: executive summary. Arthritis Rheum 38:715-718, 1995
8. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D, Goldsmith C, Kieszak S, Lightfoot R, Paulus H, Tugwell P, Weinblatt M, Widmark R, Williams HJ, Wolfe F: The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 36:729-740, 1993
9. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R Jr, Paulus H, Strand V, Tugwell P, Weinblatt M, Williams HJ, Wolfe F, Kieszak S: American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 38:727-735, 1995
10. Fried BJ, Boers M, Baker PRA: A method for achieving consensus on rheumatoid arthritis outcome measures: the OMERACT conference process. J Rheumatol 20:548-551, 1993
11. Boers M, Tugwell P, Felson DT, van Riel PLCM, Kirwan JR, Edmonds JP, Smolen JS, Khaltaev N, Muirden KD: World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol 21 (suppl 41):86-89, 1994
12. Giannini EH, Cassidy JT, Brewer EJ, Shaikov A, Maximov A, Kuzmina N: Comparative efficacy and safety of advanced drug therapy in children with juvenile rheumatoid arthritis. Semin Arthritis Rheum 23:34-46, 1993
13. Delbecq AL, van de Ven AH, Gustafson DH: Group Techniques for Program Planning: A Guide to Nominal Group and Delphi Processes. Glenview, IL, Scott, Foresman and Co., 1975
14. Brewer EJ Jr, Bass J, Baum J, Cassidy JT, Fink C, Jacobs J, Hanson V, Levinson JE, Schaller J, Stillman JS: Current proposed revision of JRA criteria. Arthritis Rheum 20:195-199, 1977
15. Cassidy JT, Levinson JE, Bass JC, Baum J, Brewer EJ Jr, Fink CW, Hanson V, Jacobs JC, Masi AT, Schaller JG, Fries JF, McShane D, Young D: A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 29: 274-281, 1986
16. Ruperto N, Levinson JE, Ravelli A, Shear ES, Tague BL, Murray K, Martini A, Giannini EH: Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. I. Outcome status. J Rheumatol 24:945-951, 1997